RxDoctor Payments Data

Michael McDaniel

Physician Assistant · Thomson, GANPI 1932327996

Payments from drug & device makers

$3,781in general payments, 2019–2025

Across 270 payments — averaging $14.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$813
  • Pfizer$269
  • Lilly USA, LLC$135
  • Bayer$135
  • Biohaven Pharmaceutical Holding Company Ltd.$125
  • plus $1K from 30 others

What the payments were for

  • Food & beverage$3,781100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,781 in reported general payments places this provider in the 85th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$21,399
Medicare patients
210
Services billed
2,890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin267$359,543
OzempicSemaglutide243$248,151
EliquisApixaban191$219,463
FarxigaDapagliflozin Propanediol89$97,950
JanuviaSitagliptin Phosphate66$83,291
Trelegy ElliptaFluticasone/Umeclidin/Vilanter102$70,699
VraylarCariprazine Hcl37$63,175
LinzessLinaclotide63$56,610
RybelsusSemaglutide21$49,159
ProliaDenosumab22$37,892
MyrbetriqMirabegron38$35,226
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog49$31,649
Nurtec OdtRimegepant Sulfate20$29,997
XareltoRivaroxaban18$26,854
TrulicityDulaglutide20$26,656

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$110$369,433278 claims
Novo NordiskOzempic, Rybelsus$813$297,310264 claims
PfizerEliquis, Nurtec Odt$269$249,460211 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$84$137,240183 claims
AbbVieVraylar, Linzess, Creon, Synthroid$1,157$132,244154 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$57$101,186167 claims
MerckJanuvia, Janumet$15$94,61280 claims
Astellas Pharma US IncMyrbetriq$51$35,22638 claims
Lilly USA, LLCTrulicity$135$26,65620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Thomson

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →